Pascal Soriot
Directeur Général chez
ASTRAZENECA PLC
Fortune : 66 M $ au 31/05/2026
Profil
Actuellement, Pascal Soriot est Chief Executive Officer & Executive Director chez AstraZeneca Plc et président d'AstraZeneca AB (une filiale d'AstraZeneca Plc). Il est également membre du conseil d'administration de Pharmaceutical Research & Manufacturers of America et d'Acerta Pharma BV. Pascal Soriot a précédemment occupé les fonctions de directeur des ventes de district chez Roussel NZ Ltd, de directeur et de directeur général du groupe Roche chez Genentech, Inc, de directeur des opérations chez Roche Pharmaceuticals, Inc, de directeur des opérations chez Sanofi-Aventis U.S. LLC et de vice-président pour l'Asie-Pacifique chez Hoechst Marion Rousel JP. Il est titulaire d'un MBA de l'École des Hautes Études Commerciales de Paris et d'un doctorat de l'École Nationale Vtrinaire d'Alfort.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ASTRAZENECA PLC 0,02 % | 14/05/2026 | 355 461 ( 0,02 % ) | 66 M $ | 31/05/2026 |
| 19/03/2026 | 2 683 ( 0 % ) | 363 627 $ | 31/05/2026 |
Dernières actualités sur Pascal Soriot
Postes actifs de Pascal Soriot
| Sociétés | Poste | Début |
|---|---|---|
| ASTRAZENECA PLC | Directeur Général | 01/10/2012 |
| AGILENT TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 20/05/2025 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Directeur/Membre du Conseil | - |
AstraZeneca Colombia SAS | Directeur Général | 01/10/2012 |
AstraZeneca Österreich GmbH
 AstraZeneca Österreich GmbH BiotechnologyHealth Technology Develops, produces and markets medicines for treatment of cardiovascular, metabolic, oncology, respiratory, infectious and autoimmune diseases | Directeur Général | - |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Directeur Général | - |
AstraZeneca Holding GmbH
 AstraZeneca Holding GmbH Financial ConglomeratesFinance Functions as an investment holding company | Directeur Général | - |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Directeur Général | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Membre du Conseil | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
Anciens postes connus de Pascal Soriot
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Pascal Soriot
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Chugai Pharmaceutical Co., Ltd.
 Chugai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures & sells pharmaceutical products | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Hoechst Marion Rousel JP
 Hoechst Marion Rousel JP Miscellaneous Commercial ServicesCommercial Services Conducts medical research | Commercial Services |
AstraZeneca Österreich GmbH
AstraZeneca Österreich GmbH BiotechnologyHealth Technology Develops, produces and markets medicines for treatment of cardiovascular, metabolic, oncology, respiratory, infectious and autoimmune diseases | Health Technology |
AstraZeneca Colombia SAS | |
AstraZeneca Holding GmbH
AstraZeneca Holding GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Roussel NZ Ltd. | |
École Nationale Vétérinaire d'Alfort
 École Nationale Vétérinaire d'Alfort Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
The Sustainable Markets Initiative |
